Difference between revisions of "ANLY482 AY2017-18T2 Group32: Project Insights"
Jump to navigation
Jump to search
Zycheng.2014 (talk | contribs) |
Zycheng.2014 (talk | contribs) |
||
Line 44: | Line 44: | ||
<div style="background: #FFFFFF;border-style:solid; border-top:0px; border-width: 2px; border-color: #000000; padding: 1em; text-align: justify;"> | <div style="background: #FFFFFF;border-style:solid; border-top:0px; border-width: 2px; border-color: #000000; padding: 1em; text-align: justify;"> | ||
− | + | We have completed our analysis for the first KPI. The following calculation was used to obtain the renewal rate for TCE products: | |
+ | |||
+ | Based on our calculations, current renewal rate for GSK is at 47%, which is quite far away from their target of 95%. In order to boost the renewal rate, we would recommend the sales team at GSk to focus on these three areas: | ||
</div> | </div> | ||
<br> | <br> |
Revision as of 23:40, 25 February 2018
Return to ANLY482 AY2017-18 Home Page
Findings
We have completed our analysis for the first KPI. The following calculation was used to obtain the renewal rate for TCE products:
Based on our calculations, current renewal rate for GSK is at 47%, which is quite far away from their target of 95%. In order to boost the renewal rate, we would recommend the sales team at GSk to focus on these three areas: